Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Selective expansion of cardiac macrophage subtypes distinguishes their functional roles in disease and homeostasis
Rajesh K. Kasam, Ronald J. Vagnozzi, Yasuhide Kuwabara, Anne Katrine Z. Johansen, N. Scott Blair, Vikram Prasad, Suh-Chin J. Lin, Akanksha Rajput, Michelle Nieman, Jeffery D. Molkentin
Rajesh K. Kasam, Ronald J. Vagnozzi, Yasuhide Kuwabara, Anne Katrine Z. Johansen, N. Scott Blair, Vikram Prasad, Suh-Chin J. Lin, Akanksha Rajput, Michelle Nieman, Jeffery D. Molkentin
View: Text | PDF
Research Article Cardiology Immunology

Selective expansion of cardiac macrophage subtypes distinguishes their functional roles in disease and homeostasis

  • Text
  • PDF
Abstract

Cardiac macrophages are broadly studied as 2 subtypes, tissue-resident CX3C chemokine motif receptor 1 positive (CX3CR1+) that are also CC motif chemokine receptor 2 negative (CCR2–) and monocyte-derived CCR2+. Previous systemic loss-of-function approaches suggested unique roles for each subtype in the heart, with CCR2+ being inflammatory and CX3CR1+ being prohealing. Here, we employed a cardiac-specific gain-of-function approach to selectively enhance either macrophage subtype. A robust increase in basal CCR2+ macrophages in the heart by targeted CC chemokine ligand 2 (Ccl2) expression did not induce inflammation, cause fibroblast activation, or impair cardiac function. However, increased CCR2+ macrophages reciprocally diminished self-renewing tissue-resident macrophages and worsened cardiac fibrosis due to pressure overload stimulation. Conversely, augmented expression of colony-stimulating factor-1 (Csf1) in the heart promoted selective expansion of resident CX3CR1+ macrophages, which exerted no pathophysiological consequences at steady state. However, pressure overload in these mice with expanded CX3CR1+ macrophages showed a CCR2+ macrophage–dependent inflammation leading to exacerbated cardiac dysfunction, simultaneously protecting from adverse remodeling and cardiac fibrosis. In conclusion, cardiac-specific selective enrichment of macrophage subtypes shows their intricate interplay and unique functional roles in regulating myocardial inflammation and fibrosis during hypertrophy and at homeostasis.

Authors

Rajesh K. Kasam, Ronald J. Vagnozzi, Yasuhide Kuwabara, Anne Katrine Z. Johansen, N. Scott Blair, Vikram Prasad, Suh-Chin J. Lin, Akanksha Rajput, Michelle Nieman, Jeffery D. Molkentin

×

Figure 7

The negative impact of augmented CX3CR1+ resident macrophages with pressure overload depends on CCR2+ cells.

Options: View larger image (or click on image) Download as PowerPoint
The negative impact of augmented CX3CR1+ resident macrophages with press...
(A) Experimental scheme showing MyoAAV-Csf1 vector or empty vector control injection at 8 weeks of age in adult Ccr2-null mice (Ccr2RFP/RFP) and then subjected to sham or TAC 3 weeks later and harvested 8 weeks after that. (B and C) Flow cytometry quantification of (B) CCR2– or (C) CCR2+ cardiac macrophages from hearts of the indicated 2 groups of Ccr2-null mice 8 weeks after sham or TAC. n = 4 mice per group, and error bars denote ± SEM. **P < 0.01, ***P < 0.001, by 1-way ANOVA with Tukey’s multiple-comparison test. (D) Ventricular weight to body weight (VW/BW) ratio in the indicated 2 groups of mice 8 weeks after sham or TAC. n = 7–12 mice per group. Error bars denote ± SEM. ****P < 0.0001, by 1-way ANOVA with Tukey’s multiple-comparison test. (E and F) Echocardiography in the indicated groups of mice subjected to sham or TAC to assess (E) fractional shortening percentage (FS%) and (F) left ventricular end diastolic dimension (LVIDd). n = 7–12 mice per group. Error bars denote ± SEM. *P < 0.05, **P < 0.01, ****P < 0.0001, by 1-way ANOVA with Tukey’s multiple-comparison test. (G–L) qRT-PCR analysis of the indicated genes from the hearts of MyoAAV-Empty– and MyoAAV-Csf1–injected mice after 8 weeks of sham or TAC. n = 5–7 mice per group and error bars denote ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, by 1-way ANOVA with Tukey’s multiple-comparison test. (M) Representative cardiac histology images with Masson’s trichrome staining for fibrosis (blue) in the 2 groups of mice 8 weeks after TAC. Scale bar = 100 μm. (N) Fibrosis percentage as the blue-stained area quantified from these Masson’s trichrome histological sections. n = 6–7 mice per group. Error bars denote ± SEM. *P < 0.05 by 2-tailed unpaired Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts